ALACHUA, Fla. – Pasteuria Bioscience has announced that it has entered into an exclusive global technology partnership with Syngenta, a world leader in agri-business focusing on sustainable agriculture. The agreement will allow for the development of innovative bio-nematicide products based on Pasteuria spp., a naturally-occurring soil bacteria long recognized as a promising biological control agent against nematodes.
"We're excited to be working in collaboration with Syngenta," said David Duncan, Ph.D., Chief Executive Officer for Pasteuria Bioscience. "This partnership is significant for the worldwide commercialization of Pasteuria-based products in a broad variety of agricultural and specialty crops."
The initial emphasis for product development will be the advancement of seed treatment products for soybean cyst nematode (SCN) control, estimated to cause more than $1 billion in crop losses each year in the United States alone. The addition of Pasteuria will complement existing Syngenta technologies and products.
"This global technology platform will offer growers a novel biological mode of action for nematode control," said Christoph Goppelsroeder, Syngenta Global Head of Seed Care. "Recent field trial results in soybean have shown encouraging results, demonstrating that this technology combined with Syngenta's seed treatment expertise can provide growers with a significant opportunity to increase their yields."